Ben Maiden is the editor-at-large of Corporate Secretary, an IR Media publication, having joined the company in December 2016. He is based in New York. Ben was previously managing editor of Compliance Reporter, covering regulatory and compliance issues affecting broker-dealers and asset management firms in the US and Europe. Before that, he was editor of Euromoney Institutional Investor’s International Financial Law Review and IFLR’s Americas editor, working in London and New York.
Latest
SEC’s climate rule leaves questions over future
The reaction to the SEC’s 3-2 decision to approve climate disclosure rule changes suggests the vote may not be the end of the...
Getting boards ready for 2024 at the Governance Intelligence Forum
Governance professionals recently gathered at the Corporate Secretary Forum – Winter in New York, hosted by Governance...
HPE and Blackbaud named best governance teams at Corporate Governance Awards
Hewlett Packard Enterprise (HPE) and Blackbaud last night won two of the top categories at the 16th annual Corporate Governance...
SEC advises companies on impact of government shutdown
The SEC’s division of corporation finance has released guidance on how a potential US government shutdown will affect its work and...
AI flashes on governance teams’ radars
In-house legal and governance teams are among the many groups taking a hard look at artificial intelligence (AI) and figuring out...
Read more
SEC adopts cyber-security rules without director expertise element
The SEC on Wednesday voted three-to-two to approve rules requiring companies to disclose material cyber-security incidents that...
Read more
ESG Integration Forum – Summer: Governance professionals eye future amid backlash
The political, and in some areas financial, pushback against ESG as a concept, even as the ways in which companies and investors...
Read more
Companies seek to limit officers’ liabilities this proxy season
Scores of Delaware-incorporated companies are sending proposals to a vote at their AGM this proxy season in an effort to limit...
Read more
Regeneron shareholders to vote on pharma patent proposal
Shareholders in Regeneron Pharmaceuticals will vote at the company’s 2023 AGM on June 9 on a proposal regarding its use of patents...
